A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck

This study was designed to evaluate the activity, safety and tolerance of docetaxel (D) in a selected population with metastatic squamous cell carcinoma of the head and neck (SCCHN). Twenty-four patients with no prior palliative therapy were enrolled and received D 100 mg m(−2) by 1 h of infusion, e...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Couteau, C, Chouaki, N, Leyvraz, S, Oulid-Aissa, D, Lebecq, A, Domenge, C, Groult, V, Bordessoule, S, Janot, F, Forni, M De, Armand, J-P
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 1999
Assuntos:
Regular Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2362927/
https://ncbi.nlm.nih.gov/pubmed/10507770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6690715
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares